“What will happen eventually is their disease symptoms and so forth will become significantly amplified,” said Dr. Michael Lacey of NeuroTrials Research in Atlanta.
He is leading a clinical trial of a medication that could bring relief.
It’s a wake-promoting drug that’s already in the pipeline for FDA approval for obstructive sleep apnea and narcolepsy.